Evaxion A EVAX
NASDAQ EVAX
$3.28 +0.01 (+0.31%)
At close: Sep 30, 2026 · 4:00 PM EDT

Evaxion A (EVAX) Shares Outstanding (Entity) (2019 - 2025)

Updated

Evaxion A's Shares Outstanding (Entity) came in at 6.41 million for Q4 2025, up 497.3% from 1.07 million a year earlier.

Analysis

Evaxion A (EVAX) Shares Outstanding (Entity) (2019 - 2025) Analysis & Trends

Going back to Q4 2019, Evaxion A's Shares Outstanding (Entity) data covers 7 quarters.

  • Shares Outstanding (Entity) has increased in each of the last seven years, with a five-year compound annual growth rate of 81.7% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 1.07 million in FY2024 (+96.2%), 546,717 in FY2023 (+13.2%), 482,788 in FY2022 (+4.0%) and 464,076 in FY2021 (+43.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Evaxion A 21.02 Mn -45.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.41 Mn
Dec 31, 2024 1.07 Mn
Dec 31, 2023 546,717.00
Dec 31, 2022 482,788.00
Dec 31, 2021 464,076.00
Dec 31, 2020 323,973.00
Dec 31, 2019 303,683.00
API Access

Evaxion A Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=EVAX&period=max&api_key=YOUR_API_KEY